Journal of Ovarian Research

Article	Citations
Serum LH levels before progesterone administration significantly affect pregnancy outcomes in hormone replacement therapy-frozen-thawed embryo transfer cycles	306
Improved clinical outcomes with a modified warming protocol in donor oocyte cycles	246
Smooth endoplasmic reticulum aggregates in oocytes: a comparison of progestin-primed and GnRH antagonist IVF protocols	123
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy	111
Endometrial HOXA-10, HOXA-11, ß-1 integrin, ECM-1, FAK, and CD44 immunohistochemical expressions in endometriosis-related recurrent IVF failure: a retrospective case-control study	91
The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis	85
An interpretable delta ultrasound radiomics model for predicting live birth outcomes in single vitrified-warmed blastocyst transfer	64
Evaluation of calcification distribution by CT-based textural analysis for discrimination of immature teratoma	60
Effects of vitrified cryopreservation duration on IVF and neonatal outcomes	56
Integrated multi-omics analysis identifies TLR4-mediated mechanisms in ATBC-induced ovarian dysfunction and female infertility: A network toxicology, transcriptomic, and Mendelian randomization study	55
Kisspeptin mediates the impact of chronic psychological stress on reproductive and metabolic dysregulation in polycystic ovary syndrome: evidence from human and rat models	52
Correction: Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance	49
Expression of long noncoding RNAs in the ovarian granulosa cells of women with diminished ovarian reserve using high-throughput sequencing	47
Role and mechanism of palmitic acid-regulated palmitoylation modification of SEC63 protein during endoplasmic reticulum stress in human ovarian granulosa tumor cells (KGN)	45
Generation of healthy bovine ovarian organoids: a proof-of-concept derivation technique	45
Integrative bioinformatics, single-cell and experimental evidence for a BPA–m6A–apoptosis axis in granulosa cell dysfunction in polycystic ovary syndrome	43
Protective effect of Luffa cylindrica fermentation liquid on cyclophosphamide-induced premature ovarian failure in female mice by attenuating oxidative stress, inflammation and apoptosis	42
The Bushen Huatan formula inhibits TP53-Mediated ferroptosis and modulating lipid metabolism in polycystic ovary syndrome abnormalities rat model	41
The presence of ovarian endometrioma adversely affect ovarian reserve and response to stimulation but not oocyte quality or IVF/ICSI outcomes: a retrospective cohort study	39
Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study	38
Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer	38
Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional mendelian randomization study	37
C-type natriuretic peptide mitigates apoptosis in ovarian granulosa cells through the cGMP pathway independent of PKG signaling	37
Prognostic significance and risk factors for pelvic and para-aortic lymph node metastasis in type I and type II ovarian cancer: a large population-based database analysis	36
HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer	35

Comparison of oocyte vitrification using a semi-automated or a manual closed system in human siblings: survival and transcriptomic analyses	35
The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome	34
Investigating the potential causal link between BPA and ovarian carcinogenesis: a network toxicology and mendelian randomization study on the CTRC/PRDX1/SKP1 pathway	34
Ascitic fluid cell block with immunocytochemistry for the diagnosis of advanced tubo-ovarian cancer: a retrospective study	33
Laser-assisted hatching is associated with reduced re-expansion of vitrified-thawed blastocysts and has no significant effect on embryo implantation	33
Multi-omics reveals the immune and metabolic characteristics and associations in non-mucinous ovarian cancer	32
An integrated machine learning-based model for joint diagnosis of ovarian cancer with multiple test indicators	31
Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer	30
Comparison of oral dydrogesterone and vaginal progesterone for luteal phase support in natural and modified natural cycle frozen embryo transfers	29
Impact of obesity on proteomic profiles of follicular fluid-derived small extracellular vesicles: A comparison between PCOS and non-PCOS women	28
Comprehensive in silico analysis of prognostic and immune infiltrates for FGFs in human ovarian cancer	28
Autophagy in ovary: protective roles, pathological consequences, and unresolved issues	28
The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis	28
Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient	27
Personalization of IVF-ICSI workflow based on patient characteristics improves IVF laboratory outcomes and embryo ploidy by PGT-A	26
Retrospective analysis of GnRH-a prolonged protocol for in vitro fertilization in 18,272 cycles in China	26
HuMSCs-derived exosomes alleviate premature ovarian insufficiency by enhancing SIRT3-mediated mitochondrial function in theca-interstitial cells	25
Causal association between metabolic syndrome and ovarian dysfunction: a bidirectional two-sample mendelian randomization	25
LncRNA DANCR counteracts premature ovarian insufficiency by regulating the senescence process of granulosa cells through stabilizing the interaction between p53 and hNRNPC	25
Cell-free DNA in female infertility: from pathological mechanisms to clinical biomarkers	25
Dose inhibin B or anti-Müllerian hormone relate to precocious puberty in girls? result of a systematic review and meta-analysis	25
β-sitosterol improves the pathological progression of PCOS by targeting ESR1 to inhibit autophagy activity	24
Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages	23
AR-mediated YBX3 suppresses oocyte meiotic resumption in polycystic ovary syndrome by attenuating Pde3A and Ccnb1 expression	23
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer	22
Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics	22
Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome	22
Prognostic marker C3AR1 is associated with ovarian cancer cell proliferation and immunosuppression in the tumor microenvironment	22
Comparative efficacy of human chorionic gonadotropin alone versus dual trigger for oocyte maturation in advanced maternal age using the antagonist protocol: a randomized controlled trial	22
M6A modification mediates CACNA1A stability to drive the progression of ovarian cancer by inhibiting ferroptosis	21
Folliculogenesis and steroidogenesis alterations after chronic exposure to a human-relevant mixture of environmental toxicants spare the ovarian reserve in the rabbit model	21
Stem cell treatments for female reproductive disorders: a comprehensive review	21
Comparison of the quality of ovarian tissue cryopreservation by conventional slow cryopreservation and vitrification—a systematic review and meta-analysis	21
CC223 enhances cisplatin sensitivity of platinum-resistant ovarian cancer by inducing cell cycle arrest	21
Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes	20
Premature ovarian insufficiency: a review on the role of tobacco smoke, its clinical harm, and treatment	20
Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experiments	20
The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities	19
The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells	19
The application value of two-dimensional ultrasound combined with contrast-enhanced ultrasound in the differential diagnosis of benign, borderline, and malignant ovarian epithelial tumors	19
Metabolic dysregulation in follicular fluid is associated with adverse reproductive outcomes in women with decreased ovarian reserve	19
In vitro drug testing using patient-derived ovarian cancer organoids	19
Insulin-like growth factor 1 as a key paracrine mediator in mesenchymal stem cell-based intervention for ovarian ageing: a review	19
Orexin antagonism and substance-P: Effects and interactions on polycystic ovary syndrome in the wistar rats	19
The landscape of transcriptional profiles in human oocytes with different chromatin configurations	19
Dual action of SS31 via NRF2/HO-1: countering oxidative stress and metabolic dysfunction in ovarian aging	19
VISTA promotes ovarian cancer progression through activation of NF-κB pathway and tumor microenvironment reprogramming	19
High expression levels of centromere protein O participates in cell proliferation of human ovarian cancer	19
SCHEMBL4796824: a multifaceted antitumor agent targeting microtubule dynamics, DNA damage, and Wnt/β-catenin signaling in ovarian cancer cells	18
Inflammasome activation contributes to cisplatin resistance in ovarian cancer	18

Roles of follicle stimulating hormone and sphingosine 1-phosphate co-administered in the process in mouse ovarian vitrification and transplantation	18
Correction: A methylation‑ and immune‑related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance	18
Hyptolide induces ER stress-mediated cell death and enhances GSK3β-regulated cisplatin chemosensitivity in ovarian cancer	18
The utility of all-freeze IVF cycles depends on the composition of study populations	18
CRISPR/Cas9-mediated activation of NR5A1 steers female human embryonic stem cell-derived bipotential gonadal-like cells towards a steroidogenic cell fate	18
Correction: Transcriptomics of cumulus cells – a window into oocyte maturation in humans	18
SOAT1 in ovarian cancer cells regulates immune response mediated by CD8+ T cells	18
The live birth rate of vitrified oocyte accumulation for managing diminished ovarian reserve: a retrospective cohort study	18
Correction: Effects and mechanisms of mUCMSCs on ovarian structure and function in naturally ageing C57 mice	18
Sempervirine inhibits proliferation, invasion and metastasis of ovarian cancer cells and induces ultrastructural changes in vivo	18
Successful treatment of Heyan Kuntai capsule combined with hormonal therapy in an adolescent with diminished ovarian reserve: a case report	17
Distinct urinary exosomal microRNAs as biomarkers for differentiating premature ovarian insufficiency and menopause	17
Development and validation of an ultrasound‑based radiomics nomogram to predict lymph node status in patients with high-grade serous ovarian cancer: a retrospective analysis	17
Ginsenoside Rb2 improves diminished ovarian reserve through regulation of gonadal hormones and apoptosis via SIRT1	17
Role of different non-coding RNAs as ovarian cancer biomarkers	17
Patient-reported outcomes after long-term period of niraparib maintenance in platinum-sensitive recurrent ovarian cancer: a prospective, multicenter cohort study	17
Molecular and cellular landscapes of the immune microenvironment and multiomic biomarker-sets in platinum-resistant recurrent ovarian cancers	17
Identification and validation of senescence-related genes in polycystic ovary syndrome	17
Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome	17
Protective effects of pistachio pericarp essential oil against diazinon-induced oxidative stress and follicular damage in the ovaries of NMRI mice	17
Assessing diagnostic accuracy of circulating microRNAs as biomarkers for ovarian cancer: a systematic review and meta-analysis	17
The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary	17
NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells	16
Anti-Müllerian hormone independently affect mtDNA copy number in human granulosa cells	16
MOCRA: A multi-algorithm clinical decision support system for the early detection of ovarian cancer	16
Mesonephric-like adenocarcinoma of the ovary	16
Up-regulated WNT5A in PCOS affects steroidogenesis, proliferation and apoptosis of granulosa cells through the PI3K/AKT pathway	16
One-carbon metabolism and risk of PCOS: insights from Mendelian randomization	16
High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer	16
Effects of coenzyme q10 supplementation on metabolic and reproductive outcomes in obese rats	16
Exploring causal relationships between brain imaging-derived phenotypes and ovarian cancer risk: a bidirectional Mendelian randomization	16
Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis	16
MMP-9 dysregulation and chronic inflammation in polycystic ovary syndrome: linking ovulatory dysfunction to diagnostic implications	16
Ultrasonographic and histopathological investigation of the effect of N-acetylcysteine on doxorubicin-induced ovarian and uterine toxicity in rats	16
MAPK signaling reprogramming via integrative TCM-Western medicine strategy: mechanistic interactions between bioactive herbal components and chemotherapy in ovarian cancer therapy — a comprehensive re	16
Unveiling the link: anti-protein disulfide isomerase A3 autoantibody expression and polycystic ovary syndrome risk in euthyroid autoimmune thyroiditis women	16
Construction and evaluation of machine learning-based prediction model for live birth following fresh embryo transfer in IVF/ICSI patients with polycystic ovary syndrome	16
Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq	16
Superovulation alters telomere length and telomerase component levels in mouse oocytes	16
Clinical significance and biological roles of lncRNA CTBP1-AS in polycystic ovary syndrome	15
Identification of TRPM2 as a prognostic factor correlated with immune infiltration in ovarian cancer	15
A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance	15
Development of machine learning models for diagnostic biomarker identification and immune cell infiltration analysis in PCOS	15
N-acetylcysteine supplementation improves endocrine-metabolism profiles and ovulation induction efficacy in polycystic ovary syndrome	15
Exosomal circ_0008285 in follicle fluid regulates the lipid metabolism through the miR-4644/ LDLR axis in polycystic ovary syndrome	15
ACSS2 promotes proliferation and invasiveness of SKOV-3 and PA-1 ovarian cancer cell lines under hypoxia	15
ARNTL deregulation promotes ovarian cancer progression and metastasis by activating cancer-associated fibroblasts	15
Triglyceride–glucose index and assisted reproductive outcomes in non-PCOS women: evidence from a propensity score–weighted cohort of 9,903 patients	15
Downregulation of FASN in granulosa cells and its impact on ovulatory dysfunction in PCOS	15
miR-34a-5p modulation of polycystic ovary syndrome via targeting the NOTCH signaling pathway	15
Correction to: Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP syntha	15
Retraction Note: Extremely active Nano-formulation of Resveratrol (XAR™) attenuates and reverses chemotherapy-induced damage in mice ovaries and testes	15
Exosomal miR-199a-3p derived from follicular fluid modulates the immune microenvironment in polycystic ovary syndrome by regulating macrophage polarization	15
Therapeutic targeting of post-translational modifications in ovarian cancer: mechanisms and clinical applications	15
Extracellular vesicle-microRNAs mediated response of bovine ovaries to seasonal environmental changes	15
Association of HOMA-IR with unexpected poor ovarian response in non-obese women in poseidon 1: a retrospective cohort study	14
Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome	14
Androgen increases klotho expression via the androgen receptor-mediated pathway to induce GCs apoptosis	14
Novel LHX8 variants associated with distinctive oocyte morphological abnormalities and maturation arrest in primary infertility	14
Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells	14
Silencing of STX4 inhibits the proliferation, migration and invasion of ovarian cancer cells via EMT/MMP2/ CCND1 signaling pathway	14
Causal pathways linking polycystic ovary syndrome to distinct breast cancer subtypes through mediator factors: a multivariable mendelian randomization analysis	14
Stage Ia squamous cell carcinoma as the malignant transformation of giant and unusual mature teratoma of the ovary in an elderly patient	14
The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome	14
CAPN2 correlates with insulin resistance states in PCOS as evidenced by multi-dataset analysis	14
Night-restricted feeding preserves the ovarian circadian rhythm of IL-17 and promotes follicular development in prepubertal and pubertal rabbits	14
Single-cell RNA sequencing reveals the role of GTF2F2 in ovarian cancer oncogenesis and progression	14
Rare variants in GPR3 in POI patients: a case series with review of literature	14
Does Anti-Müllerian hormone vary during a menstrual cycle? A systematic review and meta-analysis	14
Bushen Huatan formula alleviates polycystic ovary syndrome in rats by activating the PI3K/Akt pathway to inhibit GSDMD-mediated pyroptosis and mitochondrial damage	14
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR	14
Genome wide identification and characterization of fertility associated novel CircRNAs as ceRNA reveal their regulatory roles in sheep fecundity	14
Raddeanoside R7 inhibits proliferation and migration of ovarian cancer cells through P13K-AKT signaling	14
A primary insight into gut microbiome, MicroRNA and stemness, in a PCOS rat model	14
Proteomic and metabolomic reveals abnormalities in metabolic processes, epigenetic modifications, oxidative stress, embryonic aneuploidy and implantation in mouse blastocysts derived from in vitro fer	14
Global burden of ovarian cancer attributable to high BMI, 1990–2021: spatiotemporal trends, risk factors, frontier analysis, and projections to 2036 based on GBD 2021 study	14
Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma	13
Decoding the significance of TERT gene in Polycystic Ovary Syndrome: From molecular mechanisms to emerging diagnostic and therapeutic strategies	13
Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, HE4, and C5a	13
The impact of clinical and laboratory parameters on clinical pregnancy and live birth rates in fresh cycles: a retrospective study of 9608 high-quality cleavage-stage embryos	13

Causal association between telomere length and female reproductive endocrine diseases: a univariable and multivariable Mendelian randomization analysis	13
The stromal microenvironment of ovary: a novel area in polycystic ovary syndrome	13
Correction: Pivotal role of High-Mobility Group Box 2 in ovarian folliculogenesis and fertility	13
Retraction Note: SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer	13
Single-cell transcriptomics uncovering a critical AKT-LONP1-STAR axis in ovarian hyperandrogenism of PCOS	13
Tanshinone IIA alleviates tri-ortho-cresyl phosphate-induced ovarian damage through Hippo signaling pathway activation in mice	13
Yijing Decoction improves premature ovarian failure in rats by activating VEGF/VEGFR-2/FAK pathway	13
The efficacy and safety of novel antidiabetic agents in polycystic ovary syndrome: a network meta-analysis	13
Mass spectrometry-based untargeted metabolomics study of polycystic ovary syndrome	13
Putative “ovarian awakening” in diminished ovarian reserve: a multicenter analysis demonstrates indistinguishability from regression to the mean	13
Identification of three subtypes of ovarian cancer and construction of prognostic models based on immune-related genes	13
The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles	13
Single-cell RNA sequencing reveals the intra-tumoral heterogeneity and immune microenvironment of small cell carcinoma of the ovary, hypercalcemic type	13
Primary peritoneal clear cell carcinoma with metastasis mimicking ovarian carcinoma: a case report and literature review	13
Long non-coding RNA HCP5 accelerated malignant progression of ovarian cancer by inhibiting ferroptosis through interaction with polypyrimidine tract binding protein 1	12
Cai’s prescription inhibits granulosa cell apoptosis through ARHGAP4 on poor ovarian responders	12
Modulation of PI3K/AKT/mTOR signaling pathway by combined stem cell and phytochemical treatment improves metabolic and reproductive outcomes in PCOS	12
The efficacy of ionomycin - induced artificial oocyte activation in preventing fertilization failure in an ICSI cycle: an eight - year retrospective study	12
Identification and validation of m5c-related lncRNA risk model for ovarian cancer	12
Oleic acid activates TGFβ-Smad3 signaling to promote ovarian cancer progression	12
Intra-ovarian platelet-rich plasma administration plus successive accumulated embryo transfer could be a promising strategy for poor ovarian response management: a before-after study	12
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma	12
Extracellular vesicles-derived MicroRNA-145-5p is upregulated in the uterine fluid of women with endometriosis and impedes mouse and human blastocyst development	12
The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma	12
Erzhi Tiangui formula increases the number of high-quality blastocysts in patients with advanced age by regulating the Nrf2/HO-1 signaling pathway: a randomized controlled study	12
Prognostic modeling of endometriosis-associated ovarian cancer based on molecular signatures: a retrospective study	12
Epigenetic regulation by DNA methylation in PCOS and POI: mechanisms of ovarian dysfunction and implications for clinical research	12
Upregulation of TRPS1 promotes proliferation, migration, and invasion in ovarian clear cell carcinoma and correlates with poor patient prognosis	12
Pretreatment with or without GnRH-agonist before frozen–thawed embryo transfer in patients with PCOS: a systematic review and meta-analysis	12
Initiation and elongation factor co-expression correlates with recurrence and survival in epithelial ovarian cancer	12
Mitochondrial dysfunction in oocytes: implications for fertility and ageing	12
Past and present: a bibliometric study on polycystic ovary syndrome	12
Integrative metabolomics and proteomics reveal early cardiovascular risk signatures in PCOS female offspring	12
SS-31 improves the quality of maternally aged oocytes by ameliorating mitochondrial function and metabolism	12
Identification of DHX58 as a potential therapeutic target for ovarian cancer through multi-omics Mendelian randomization and transcriptomic data analysis	12
In-vitro generation of follicle-like structures from human germ cell-like cells derived from theca stem cell combined with ovarian somatic cells	12
Carvacrol ameliorates cyclophosphamide-induced rat premature ovarian failure and uterine fibrosis via regulating PI3K/AKT/FOXO3a signaling pathway	11
Sterigmatocystin declines mouse oocyte quality by inducing ferroptosis and asymmetric division defects	11
O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses	11
Correction: Bone marrow mesenchymal stem cells expressing Neat-1, Hotair-1, miR-21, miR-644, and miR-144 subsided cyclophosphamide-induced ovarian insufficiency by remodeling the IGF-1–kisspeptin syst	11
circVEGFA inhibits apoptosis in porcine ovarian granulosa cells by binding to miR-21-3p and up-regulating TMX4 expression	11
A real-world study of treatment patterns following disease progression in epithelial ovarian cancer patients undergoing poly-ADP-ribose polymerase inhibitor maintenance therapy	11
Ulinastatin protects against cisplatin-induced ovarian damage via Nrf2/Keap1 pathway	11
Epitranscriptome marks detection and localization of RNA modifying proteins in mammalian ovarian follicles	11
Spontaneous ovulation, hormonal profiles, and the impact of progesterone timing variation on outcomes in natural proliferative phase frozen embryo transfer cycles with single euploid blastocyst transf	11
Potential use of DNA methylation in cervical swabs for early ovarian cancer diagnosis	11
Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization/ intracytoplasmic sperm injection cycles: a systematic review with meta-analysis	11
Atractylenolide III mitigates polycystic ovary syndrome by activating FDX1-mediated proliferation of ovarian granulocyte cells via PI3K/AKT/mTOR	11
Integrative multi-omics analysis of druggable genes for therapeutic target identification in polycystic ovary syndrome	11
Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6	11
Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer	11
Accurate prediction of benign and malignant adnexal tumors in surgical resection and conservative treatment: construction and external validation of a diagnostic model based on CEUS, HE4, and O-RADS U	11
Effects of n-3 PUFA supplementation on oocyte in vitro maturation in mice with polycystic ovary syndrome	11
ATF3 mediates PM2.5-induced apoptosis and inflammation in ovarian granulosa cells	11
Gut microbiota and ovarian diseases: a new therapeutic perspective	11
Loss of Calponin 2 causes premature ovarian insufficiency in mice	11
Malignant ascites in ovarian cancer is compatible with long-term (10 year) survival with associations to clinicopathological features	11
Clinical characteristics and risk factors of ovarian reserve decreases in women with Crohn’s disease: a case-control study	11
Amplifications of EVX2 and HOXD9-HOXD13 on 2q31 in mature cystic teratomas of the ovary identified by array comparative genomic hybridization may explain teratoma characteristics in chondrogenesis and	11
Pretreatment with a long-acting GnRH agonist for frozen-thawed embryo transfer cycles: how to improve live birth?	11
Investigation of androgen receptor CAG repeats length in polycystic ovary syndrome diagnosed using the new international evidence-based guideline	10
Diagnostic utility of a conventional MRI-based analysis and texture analysis for discriminating between ovarian thecoma-fibroma groups and ovarian granulosa cell tumors	10
Progestin and adipoQ receptor 7 (PAQR7) mediate the anti-apoptotic effect of P4 on human granulosa cells and its deficiency reduces ovarian function in female mice	10
Role of the tumor microenvironment in chemotherapy resistance in ovarian cancer and targeted therapy	10
Curcumin and its formulations for the treatment of polycystic ovary syndrome: current insights and future prospects	10
Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review	10
The role of vitamin D3 in follicle development	10
Unveiling the role of the PI3K/Akt signaling pathway in follicular development and non-malignant ovarian dysfunction: a comprehensive review	10
Mechanisms and treatment modalities related to premature ovarian insufficiency in mitochondria: literature review	10
Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases	10
The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer	10
Healthy live birth after microsurgical enucleation of tripronuclear human zygote derived from ICSI: a case report	10
DNA methylation-regulated AKAP12 expression modulates ECM remodeling and ADP/FAD ratio to influence prognosis in ovarian cancer	10
Deciphering the interplay between oxidative stress and inflammation in polycystic ovary syndrome: outcome of a case-control study	10
LH level on ovulation trigger day has a different impact on the outcomes of agonist and antagonist regimens during in vitro fertilization	10
Multitask deep learning models for ultrasound image analysis: identification of high-grade serous ovarian cancer and segmentation of tumor regions and intratumoral solid components	10
Development of a diagnostic model for ovarian cancer based on machine learning algorithms and functional analysis of key biomarker SOX17	10
Development of a recurrence-related gene signature and functional role of MLLT6 in ovarian cancer progression and Paclitaxel resistance	10
Correlation between the follicular fluid extracellular-vesicle-derived microRNAs and signaling disturbance in the oocytes of women with polycystic ovary syndrome	10
Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer	10
Unraveling the role of lipid metabolism in polycystic ovary syndrome through multi-omics Mendelian randomization	10
Machine learning models in evaluating the malignancy risk of ovarian tumors: a comparative study	10
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors	10
RNA sequencing in ovarian cancer research: a comprehensive review	10
Differences between complex epithelial neoplasms of the ovary and high-grade serous ovarian cancer: a retrospective observational cohort study	10
Effect of Nigella sativa-L supplementation on glycemia in adolescent polycystic ovarian syndrome: secondary analysis of a randomized controlled trial study	10
UBE2T regulates epithelial–mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer	10
Multi-omics reveal the metabolic patterns in mouse cumulus cells during oocyte maturation	10
The mechanism and protective strategies of follicle injury after ovarian tissue cryopreservation and thawed transplantation: a review	10
Platelet-rich plasma activation: are there differential effects in reproductive medicine?	10
Application of comprehensive unit-based safety program model to improve chemotherapy-induced nausea and vomiting in patients with ovarian cancer: a retrospective study	10
Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells	9
Extracellular vesicles and their content in the context of polycystic ovarian syndrome and endometriosis: a review	9
A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer	9
MSCs–derived EVs protect against chemotherapy-induced ovarian toxicity: role of PI3K/AKT/mTOR axis	9